Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis

Anthony J Fischer1, Sachinkumar B Singh1, Mason M LaMarche1

  • 1Stead Family Department of Pediatrics.

Insights

Pseudomonas aeruginosa does not replace Staphylococcus aureus in cystic fibrosis (CF) patients over time. Both bacteria persist, and coinfection prevalence increases, challenging previous assumptions and necessitating new treatment strategies for CF airway infections.

Area of Science:

  • Microbiology
  • Pulmonology
  • Infectious Diseases

Background:

  • Staphylococcus aureus and Pseudomonas aeruginosa are common airway pathogens in cystic fibrosis (CF).
  • Previous studies suggested P. aeruginosa replaces S. aureus in older CF patients.
  • In vitro studies show P. aeruginosa can inhibit S. aureus growth.

Purpose of the Study:

  • To investigate the longitudinal dynamics of S. aureus and P. aeruginosa infections in CF patients.
  • To determine if P. aeruginosa replaces S. aureus over time in CF airways.
  • To analyze the prevalence and abundance of these coinfections.

Main Methods:

  • Longitudinal cohort study of 134 CF patients with quantitative sputum cultures (2004-2017).
  • Measured abundance (cfu/ml), duration, and persistence of S. aureus and P. aeruginosa infections.
  • Analyzed changes in culture positivity and bacterial abundance over a median observation time of 10.15 years.

Main Results:

  • Both S. aureus and P. aeruginosa were abundant (median >10^6 cfu/ml) and stable in CF sputum cultures.
  • No evidence of S. aureus replacement by P. aeruginosa was observed over time.
  • Prevalence of S. aureus/P. aeruginosa coinfection increased, with no decrease in individual S. aureus prevalence.

Conclusions:

  • S. aureus and P. aeruginosa coexist and persist in CF airways, contrary to replacement assumptions.
  • Durable, long-term coinfections are common in CF patients.
  • Novel strategies are required for the prevention and treatment of these persistent coinfections in CF.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
609
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
335
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
418